Cholangiocarcinoma, also known as bile duct cancer, is a rare disease. It's a devastating condition incurable at the point ...

肝内胆管癌 (intrahepatic cholangiocarcinoma, iCCA)的预后不佳，很大原因是由于诊断不够及时造成的，因此iCCA的早期诊断和及早治疗是提高疾病治愈效果的 ...

Intraductal neoplasms of the bile duct are macroscopically characterized by exophytic or polypoid growth patterns and have a favorable prognosis. Although some tumors with a predominantly tubular ...

Cholangiocarcinoma is a relatively rare adenocarcinoma of the bile ducts that is rapidly fatal unless it can be completely resected. In most cases, the tumor is too advanced for resection by the ...

Across the 3 cholangiocarcinoma subtypes, OS of more than 3 years was associated with lower percentages of PD-1+ cells among the CD8+ T cells than those with OS of less than 3 years.

The albumin-bilirubin (ALBI) score can independently predict prognosis in post-surgical patients with distal cholangiocarcinoma (dCCA), a form of cholangiocarcinoma (CCA), according to results ...

Optimism Remains as Cholangiocarcinoma Becomes the ‘Poster Child’ for Targeted Therapy Even though cholangiocarcinoma is a rare cancer, Valle said that he is still optimistic about the future of the ...

The “ubiquitous dependency” of cholangiocarcinoma on CDK4/6 activity, Kongpetch said, suggests that the that the CDK4/6-pRB pathway could be a treatable target.

Cholangiocarcinoma, known more commonly as bile duct (or biliary) cancer, has several features that historically have made it difficult to treat. First, it is a rare cancer, so advances in treatment ...

Results showed that across 3,038 U.S. counties there were 85,909 cholangiocarcinoma cases and 23,902 cholangioscopies performed — an annual mean volume of 2.5 (standard deviation, 7.1 ...

The magnetic resonance (MR) imaging appearance of cholangiocarcinoma depends on the amount of fibrosis, necrosis, and mucinous material within the tumor. Most frequently it appears as a ...